Ascendis Pharma AS (ASND)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
14,840,729,000
EV to revenue ratio (TTM)
11.9
EV to ebitda
65.35
Financial Performance
Revenue (TTM)
1,047,020,000
Gross profit (TTM)
955,895,000
EBITDA
263,454,000
Profitability
Operating margin (TTM)
65.00%
Profit margin
70.90%
Return on assets (TTM)
9.58%
Return on equity (TTM)
118.80%
Per Share Metrics
Revenue per share (TTM)
16.89
EPS
12.8
Diluted EPS (TTM)
12.8
Book value
24.89
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
17.62
Trailing P/E
17.62
Forward P/E
19.84
PEG ratio
Price to sales ratio (TTM)
14.17
Price to book ratio (TTM)
8.91
Growth
Quarterly earnings growth (YoY)
114.70%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
4
Buy
16
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.485